アジア全域における米国での突然心臓死予防のためのカテーテルアブレーション試験

基本情報

NCT ID

NCT02848781

ステータス

完了

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

180

治験依頼者名

University of Arizona

概要

The current standard of care for ventricular tachycardia (VT) includes the use of medicine called anti-arrhythmic drugs (AADs) and Implantable Cardioverter Defibrillator (ICD) therapy. These treatments are used to terminate the irregular heartbeats and bring the heart back to a normal rhythm. Catheter ablation is a procedure used to eliminate (damage) the heart cells causing the arrhythmia. Patients eligible for this may benefit from an ablation procedure in addition to an ICD to treat their VT condition or risk of developing VT. This study aims to show that treating VT with catheter ablation, if performed preemptively at the time of ICD implantation, will reduce subsequent recurrent VT, ICD shocks, and lead to improved survival.

対象疾患

介入

依頼者（Sponsor）

実施施設 (3)